$ALKS Recent News Despite Fed concerns, technicals

New Post Public Reply Private Reply Replies (0) Message Board

Jan 10, 2014 at 11:53 AM

$ALKS Recent News

Despite Fed concerns, technicals support bull case 1:16 p.m. Sept. 17, 2013 - Michael Ashbaugh
Despite Fed concerns, technicals support bull case 12:02 p.m. Sept. 17, 2013 - Michael Ashbaugh
Biogen, InterMune, Alkermes all make stock waves with earnings 1:28 p.m. July 25, 2013 - Russ Britt
Reading the fine print turns initial Alkermes share loss into a gain 10:49 a.m. May 23, 2013 - Russ Britt
Health stocks ride potential, momentum to a higher close 3:37 p.m. April 19, 2013 - Russ Britt
Alkermes shares surge on positive results for depression disorder drug 12:20 p.m. April 17, 2013 - Russ Britt
S&P, Dow hold tightly to resistance 11:04 a.m. Oct. 8, 2012 - Michael Ashbaugh
Stocks to watch Thursday: Alkermes, Tilly’s 5:42 a.m. May 31, 2012 - MarketWatch
Amylin rallies 20% on diabetes drug approval 11:18 a.m. Jan. 30, 2012 - Val Brickates Kennedy
U.S. futures lower; Pep Boys, Thomas & Betts gain 9:30 a.m. Jan. 30, 2012 - Kate Gibson
PharMerica dives, Amylin surges after hours 7:11 p.m. Jan. 27, 2012 - Carla Mozee
Stocks to Watch Monday: Alkermes, Amylin 6:10 p.m. Jan. 27, 2012 - David B. Wilkerson
FDA approves Amylin's Bydureon diabetes drug 5:56 p.m. Jan. 27, 2012 - MarketWatch.com
Alkermes resumes trading, up 4.7% after hours 4:19 p.m. Jan. 27, 2012 - Carla Mozee
Amylin shares resume trading, up 15% after hours 4:16 p.m. Jan. 27, 2012 - Carla Mozee
FDA approves Alkermes/Amylin drug Bydureon 4:06 p.m. Jan. 27, 2012 - Val Brickates Kennedy
Amlyin, Alkermes to resume trade at 4:15 p.m. EST 4:01 p.m. Jan. 27, 2012 - Carla Mozee
FDA approves Alkermes/Amylin diabetes drug 3:54 p.m. Jan. 27, 2012 - Val Brickates Kennedy
Alkermes, Amylin halted as FDA deadline approaches 2:17 p.m. Jan. 27, 2012 - Val Brickates Kennedy
Amylin, Alkermes shares halted pending news 2:05 p.m. Jan. 27, 2012 - Wallace Witkowski

Is This the Top for Alkermes Plc (ALKS)? - Tale of the Tape 8:31 a.m. Jan. 9, 2014 - Zacks.com
J.P. Morgan Top Biotechnology Stocks to Buy for 2014 7:39 a.m. Jan. 8, 2014 - 247WallSt.com
Alkermes Announces Advances in Late-Stage CNS Pipeline 6:02 a.m. Jan. 8, 2014 - benzinga.com
Notice of Allowance Received by Alkermes - Analyst Blog 4:21 p.m. Jan. 7, 2014 - Zacks.com
Alkermes Receives Notice of Allowance of US Patent for Novel Fumarate Prodrug for MS 6:04 a.m. Jan. 6, 2014 - benzinga.com
Analysts Issue Bullish Biotech Outlooks for '14, Except Goldman, Which Is Negative 6:03 a.m. Jan. 6, 2014 - TheStreet.com
Insider Trading Alert - UNP, FIS, JBL, MAT And ALKS Traded By Insiders 10:01 a.m. Dec. 30, 2013 - TheStreet.com
Alkermes: 7 Different Insiders Have Sold Shares This Month 2:45 a.m. Dec. 30, 2013 - Seeking Alpha
Alkermes Larger Than S&P 500 Component Legg Mason 4:38 p.m. Dec. 27, 2013 - TheStreet.com
Ireland Home To Several Fast Growing Health Care Names 4:02 p.m. Dec. 24, 2013 - Investors Business Daily
Alkermes plc (ALKS): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Dec. 16, 2013 - Zacks.com
Alkermes Presents Data on Aripiprazole Lauroxil and ALKS 5461 at 52nd Annual ACNP Meeting 6:13 a.m. Dec. 9, 2013 - benzinga.com
3 Stocks Dragging In The Health Care Sector 12:06 p.m. Dec. 5, 2013 - TheStreet.com
Analysts Actions: ALKS CELG HK ORCL S 8:11 a.m. Dec. 5, 2013 - TheStreet.com
Pharma & Biotech Stock Outlook - Dec 2013 - Zacks Analyst Interviews 4:28 a.m. Dec. 3, 2013 - Zacks.com
Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook 4:28 a.m. Dec. 3, 2013 - Zacks.com
Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook 4:28 a.m. Dec. 3, 2013 - Zacks.com
Insider Trading Alert - CBI, IPG, SAPE, ALKS And CSCO Traded By Insiders 1:15 p.m. Nov. 25, 2013 - TheStreet.com
Insider Trading Alert - CBI, IPG, SAPE, ALKS And CSCO Traded By Insiders 1:03 p.m. Nov. 25, 2013 - TheStreet.com
Can Alkermes Plc (ALKS) Continue to Rise? - Tale of the Tape 11:19 a.m. Nov. 25, 2013 - Zacks.com

Technical Dossier: Theravance, Alkermes, Cubist Pharma, and TherapeuticsMD 8:00 a.m. Jan. 8, 2014 - PR Newswire
Alkermes Announces Advances With Its Late-Stage CNS Pipeline 7:00 a.m. Jan. 8, 2014 - BusinessWire
Alkermes' Corporate Presentation to be Webcast at the 32nd Annual J.P. Morgan Healthcare Conference 4:00 p.m. Jan. 7, 2014 - BusinessWire
Alkermes Announces Notice of Allowance of U.S. Patent for a Novel Fumarate Prodrug for Multiple Sclerosis 7:00 a.m. Jan. 6, 2014 - BusinessWire
FDA Consents, Pending Acquisition Approvals, Program Deployments, and Stock Movements - Research Report on Gilead, Elan, Agilent, Alkermes and Hospira 8:00 a.m. Dec. 18, 2013 - PR Newswire
Morning Research Covering Healthcare Sector: Hospira, Alkermes, Theravance, and Celsion 12:24 p.m. Dec. 10, 2013 - PR Newswire
Alkermes Presents Data on Two Late-Stage Clinical Candidates, Aripiprazole Lauroxil and ALKS 5461, at 52nd Annual ACNP Meeting 7:00 a.m. Dec. 9, 2013 - BusinessWire
Stock Price Movement and Senior Notes Redemption - Research Report on Valeant, Edwards Lifesciences, Alkermes, Mallinckrodt, and Dr. Reddy's 8:00 a.m. Dec. 6, 2013 - PR Newswire
Approved Acquisition, FDA Approvals, Senior Note Offerings, and Announcements by Drug Delivery Companies - Research Report on Elan, IntelliPharmaCeutics, Valeant Pharmaceuticals, Hospira, and Alkermes 8:00 a.m. Nov. 22, 2013 - PR Newswire
Before the Bell Scans: Theravance Inc., Alkermes PLC, Celsion Corp., and Hospira Inc. 6:23 p.m. Nov. 14, 2013 - PR Newswire
Acquisitions, Clinical Trial Results and Stock Price Movements - Research Report on ViroPharma, Pfizer, Alkermes, Tenet, and ResMed 8:00 a.m. Nov. 14, 2013 - PR Newswire
Advancing Pipelines, Liquidity Growth, Cost-reduction Initiatives and Breakthrough Studies - Research Report on Alkermes, Abiomed, Gentium, Amarin, and VIVUS 8:00 a.m. Nov. 6, 2013 - PR Newswire
Alkermes' Corporate Presentation to be Webcast at the Credit Suisse 2013 Healthcare Conference 4:00 p.m. Nov. 5, 2013 - BusinessWire
Alkermes plc Reports Financial Results for Quarter Ended Sept. 30, 2013 6:00 a.m. Oct. 31, 2013 - BusinessWire
New Appointments, Upcoming Earnings Releases, Regulatory Approvals, Status Updates and Informative Resources for New Treatment Options - Research Report on Mylan, Alkermes, Salix, Ligand and Hospira 8:31 a.m. Oct. 30, 2013 - PR Newswire
Alkermes to Host Conference Call to Discuss Financial Results for Quarter Ended Sept. 30, 2013 3:00 p.m. Oct. 24, 2013 - BusinessWire
Pre-Market Review: Alkermes PLC, Hospira Inc., Celsion Corp., and Theravance Inc. 8:30 a.m. Oct. 24, 2013 - PR Newswire
Alkermes Receives Fast Track Designation for ALKS 5461 for Major Depressive Disorder 6:00 a.m. Oct. 10, 2013 - BusinessWire
Alkermes Announces Alignment with FDA on Plans for Pivotal Program for ALKS 5461 for Major Depressive Disorder 6:00 a.m. Oct. 9, 2013 - BusinessWire
Alkermes Announces Completion of Patient Enrollment in Pivotal Phase 3 Study of Aripiprazole Lauroxil 6:00 a.m. Oct. 8, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Equity Alerts: Unraveling the Latest M&A Surprises

Diving Into the M&A Controversy On the bustling streets of New York, beneath the towering Empire State Building, a plot unfolds that could shake the foundations of your investments—particularly if you're holding shares in Synaptics, Eagle Financial, Victory Capital, or Centerspace. Juan Monteverde and his legal firepower from Monteverde & Associates PC are launching a...

Anita Eno: 2027's Top Trailblazing Businesswoman

Anita Eno's Well-Deserved Recognition You've got to respect a story where someone claws their way up from humble beginnings to a position of serious influence. Anita Eno, Founder and CEO of Prayers Are Answered Inc., is one of those impressive figures, recently bagging the 2027 American Business Woman of the Year title. This accolade, dished out by the American Business...

SINBON's Role in Sustainable Tech Showcase at 2026 Fairs

Get this: What do hospitals, charging stations, and data centers have in common? Well, they all rely on data and power connections that are largely invisible but absolutely fundamental to keeping the gears of modern life grinding. SINBON Electronics is stepping up at electronica and SPS 2026, showing how their nifty gadgets transform mundane wires into the beating heart...

Mili and Egnyte Transform Financial Advice Delivery

AI Powers Up Financial Advisors with New Partnership Ah, the grind never ends for those financial advisors, right? Well, here's a nugget that might just lighten their load. Mili and Egnyte are buddying up to merge AI with secure content platforms, aiming to supercharge how advisors handle client documents. Right off the bat, advisors can crank out personalized advice at a...

AI Traffic Sensing By AglaiaSense and Leopard Imaging

Revolutionizing Traffic Sensing with Privacy The buzz in Barcelona this November is all about AglaiaSense and Leopard Imaging teaming up at the Smart City Expo World Congress. They're not just hitting exhibit after exhibit. These two are set to roll out their cutting-edge AI traffic sensing tech, and from what I'm hearing, it's miles ahead of anything we've seen before....

Valens' Q3 2026 Earnings: What’s on the Horizon?

Valens' Upcoming Earnings: Buckle Up, Investors! Alright folks, here’s the scoop straight from the trenches. Valens Semiconductor, ticker NYSE:VLN, is about to drop its third quarter earnings results. Mark your calendars for November 11, 2026, because that's when the numbers hit the fan. The conference call is set for a bright and early 8:30 AM ET. If you’re placing...

Labcorp Scoops Up BioReference Health For $722M+

Picture this: You’re a big fish like Labcorp ready to feast on smaller catches. That’s exactly what’s rolling out as OPKO Health cuts a deal to offload a chunk of its BioReference Health assets to Labcorp for a tidy $722 million in cash. Assets on the Move OPKO’s BioReference Health has long been a player in the clinical testing world, with a focus on services...

Annual Flu Shots May Save Lives: Accordia Health's Call

Flu Season Isn't Just Sniffles: Accordia Health Speaks Up Listen up folks, it’s that time again and no, it ain’t just about digging out last year's scarf. Flu season is rolling in faster than a train outta hell, and already folks are talking about flu cases creeping up during the summer sunshine. We got Dr. Cameron Kilpatrick over at Accordia Health ringing the bell...

Fire Safety in Focus as Lithium Battery Problem Grows

Everyone’s eyeballs are glued to the burning issue of lithium-ion battery fires, and for good reason. They’re ticking time bombs, especially in those fancy new electric vehicles and gadgets. But stepping into the ring with solutions like they’re fighting windmills, Packaging and Crating Technologies (PACT®) took the spotlight at the recent Battery Show in Detroit,...

Ben Felton to Lead AEIC as President for 2027

A New Face at the Helm of AEIC If you’ve been keeping tabs on the utility sector, then the recent shuffling of chairs over at the Association of Edison Illuminating Companies (AEIC) might have caught your eye. They just wrapped up their 142nd Annual Meeting in Ojai, where Ben Felton from Portland General Electric stepped into the limelight as the incoming President for...